Probe-free RT-PCR COVID-19 detection assay developed by IIT Delhi
A low-cost, probe-free RT-PCR COVID-19 detection assay developed by IIT Delhi will be launched tomorrow (July 15). The assay
Read More
SARS-CoV-2
Aptamer-based assay developed for coronavirus detection
Researchers from the Faridabad-based Translational Health Science and Technology Institute (THSTI) have developed an Aptamer-based assay for novel coronavirus
Read More
U.S. reports 30,755 excess, unaccounted deaths by end-April
When COVID-19 deaths in the U.S. stood at 56,246 on April 25, it is been estimated that 30,755 excess
Read More
Some people unexposed to novel coronavirus have pre-existing immunity
At least five studies found people unexposed to novel coronavirus exhibiting T cell immune responses specific to SARS-CoV-2. This
Read More
Exhaled breath of COVID-19 patients found to contain novel coronavirus
The study found a few patients exhaled coronavirus into the air at an estimated rate of 1000-1,00,000 RNA copies/minute.
Read More
WHO acknowledges airborne transmission of coronavirus in closed settings, and asymptomatic spread
The World Health Organization on July 9 acknowledged that novel coronavirus can be airborne in closed settings and spread
Read More
U.S. withdrawal from WHO is a lose-lose proposition for all
The capricious decision to withdraw from WHO will have dire consequences for global public health. The departure of the
Read More
COVID-19: China’s dangerous obsession with secrecy a serious threat to global public health
Contrary to what was earlier reported, China confirmed to the WHO of the cluster of cases of ‘viral pneumonia
Read More
Completion of COVID-19 vaccine trials could take at least six-nine months, says Soumya Swaminathan
A realistic (but very optimistic) timeline from the start of Phase-1 to the completion of Phase-3 could be about
Read More
Meta-analysis does not support continued use of point-of-care serological tests for COVID-19
A systematic review and meta-analysis of 40 studies of antibody testing for novel coronavirus (SARS-CoV-2) has found “major weaknesses”
Read More
A day after ICMR faces flak, it reverses stand and says fast-tracking was only to cut red tape
A day after serious concerns were raised, ICMR has reversed its stand. It says its decision to fast-track the trial
Read More
SARS-CoV-2: Finally, India shares genome sequence data with GISAID
A day after I reported that India has not shared genome sequence data of the novel coronavirus (SARS-CoV-2) with GISAID,
Read More
India yet to share genome sequence data of novel coronavirus even as 23 countries have done so
Even as 23 countries, including Nepal, Vietnam and Cambodia, have shared genome sequence data of the novel coronavirus, India has
Read More